EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Asthma Alleviation by Ginsenoside Rb1 via Promotion of Treg Proliferation and Inflammatory T Cell Inhibition

Susanna Choi iD, Seung-Ah Yoo, Kon-Young Ji, Dong Ho Jung iD, Saseong Lee, Kang-Gu Lee, Ki-Myo Kim, Joo Young Lee, Myung-A Jung, Bo-Jeong Pyun, Jung Hur, Joon Young Choi und 3 weitere

Allergy · 2025-06 · 80 (6) · 1647-1668

DOI: 10.1111/all.16551 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergy, online erschienen am 19.04.2025. Verfasst von Susanna Choi und 14 weiteren Autor:innen. Beteiligte Einrichtung: KM Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea. Hauptthemen laut MEDLINE: Ginsenosides, T-Lymphocytes, Regulatory, Asthma. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korea Institute of Oriental Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Regulatory T cells (Tregs) are living drugs with feasibility, tolerability, and therapeutic benefits. Although Tregs are linked to asthma prognosis through inflammation regulation, no therapeutic agents specifically designed to manage asthma by upregulating Tregs have been developed to date.

Methods

We screened a library of 250 natural products using a cytometric bead array. Among the selected candidates, gRb1 was identified for further investigation. The effects of gRb1 on Treg and Th17 populations were evaluated in mouse asthma models and human PBMCs from both healthy donors and asthma patients using flow cytometry and cytokine analysis.

Results

In inflammatory conditions, ginsenoside Rb1 (gRb1, a major ginseng component) increased IL‐10‐ and TGF‐β‐expressing Treg populations and decreased the Th17 population; activated phospho‐STAT5 and NFAT1 in Tregs; inhibited NFAT1 activation in conventional T cells (Tconvs); increased Treg proliferation and Tconv–Treg differentiation, inhibiting Tconv proliferation; and reduced inflammatory cytokine secretion by Tconvs. In asthma model mice, suppression of asthma symptoms by gRb1 was associated with elevated Treg and lower Th17, Th1, and Th2 counts. gRb1 treatment of stimulated PBMCs from patients with asthma and healthy donors increased IL‐10‐ and TGF‐β‐expressing Treg populations and decreased IL‐17A‐, IL‐22‐, IFN‐γ‐, and TNF‐α‐expressing T‐cell populations. Conclusions gRb1 alleviate asthma by shifting the Treg–inflammatory T cell balance. These findings suggest a strategy for enhancing Treg activity through treatment with gRb1. This may provide a novel therapeutic approach for asthma and related disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GinsenosidesT-Lymphocytes, RegulatoryAsthmaAnimalsHumansMiceDisease Models, AnimalCytokinesCell ProliferationLymphocyte ActivationFemaleT-Lymphocyte SubsetsMale

Stichwörter der Autor:innen

Panax ginsengTregasthmaginsenoside Rb1inflammationscreening

Substanzen

Ginsenosidesginsenoside Rb1Cytokines

Autor:innen und Institutionen

  • KM Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea.
  • Department of Medical Life Sciences, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Center for Integrative Rheumatoid Transcriptomics and Dynamics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Department of Plastic and Reconstructive Surgery, Seoul National University College of Medicine, Seoul National University Boramae Hospital, Seoul, Republic of Korea.
  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Republic of Korea.

ORCID-Profile: Susanna Choi, Dong Ho Jung

Förderung

  • Korea Institute of Oriental Medicine

Zitieren

APA

Choi, S., Yoo, S. A., Ji, K. Y., Jung, D. H., Lee, S., Lee, K. G., Kim, K. M., Lee, J. Y., Jung, M. A., Pyun, B. J., Hur, J., Choi, J. Y., Rhee, C. K., Kim, W. U., & Kim, T. (2025). Asthma Alleviation by Ginsenoside Rb1 via Promotion of Treg Proliferation and Inflammatory T Cell Inhibition. Allergy, 80(6), 1647-1668. https://doi.org/10.1111/all.16551

Vancouver

Choi S, Yoo SA, Ji KY, Jung DH, Lee S, Lee KG, et al. Asthma Alleviation by Ginsenoside Rb1 via Promotion of Treg Proliferation and Inflammatory T Cell Inhibition. Allergy. 2025;80(6):1647-1668. doi:10.1111/all.16551

BibTeX
@article{Choi2025,
  author = {Choi, Susanna and Yoo, Seung-Ah and Ji, Kon-Young and Jung, Dong Ho and Lee, Saseong and Lee, Kang-Gu and Kim, Ki-Myo and Lee, Joo Young and Jung, Myung-A and Pyun, Bo-Jeong and Hur, Jung and Choi, Joon Young and Rhee, Chin Kook and Kim, Wan-Uk and Kim, Taesoo},
  title = {Asthma Alleviation by Ginsenoside Rb1 via Promotion of Treg Proliferation and Inflammatory T Cell Inhibition},
  journal = {Allergy},
  year = {2025},
  volume = {80},
  number = {6},
  pages = {1647--1668},
  doi = {10.1111/all.16551}
}
Kostenlos starten →